JNMT
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stokkel, M. P.M.
Right arrow Articles by Blokland, K. A.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stokkel, M. P.M.
Right arrow Articles by Blokland, K. A.K.
Journal of Nuclear Medicine Technology Volume 35, Number 1, 2007 21-26
© 2007 by Society of Nuclear Medicine

Reproducibility of a Standardized Quantitative Analysis Using Fixed Regions of Interest to Differentiate Movement Disorders on 123I-FP-CIT SPECT

Marcel P.M. Stokkel, Petra Dibbets-Schneider, Elke Koestering, Constantin Dragoiescu and Koos A.K. Blokland

Department of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands

Correspondence: For correspondence or reprints contact: Marcel P.M. Stokkel, MD, PhD, Department of Nuclear Medicine, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. E-mail: m.p.m.stokkel{at}lumc.nl

The present prospective study evaluated the diagnostic value of a standardized analysis of 123I-N-{omega}-(fluoropropyl)-2ß-carbomethoxy-3ß-(4-iodophenyl)tropane (FP-CIT) SPECT studies acquired on a triple-head {gamma}-camera for patients with clinically uncertain movement disorders having tremor as the most striking feature. Methods: 123I-FP-CIT studies were performed on 52 consecutive patients (27 male and 25 female; mean age, 49.2 y; range, 17–80 y) who had a clinical diagnosis of Parkinson's disease (PD) (n = 21), hypokinetic rigid syndrome (n = 19), dystonia (n = 8), or essential tremor (n = 4). In all patients, the final diagnosis was based on a thorough clinical examination, the family history, and a 2-y follow-up. Two independent technologists analyzed 123I-FP-CIT studies using a standardized quantitative method applying both fixed regions of interest (ROIs) and manually drawn ROIs. The mean values from both methods were compared using the Student t test, and the intra- and intertechnologist variabilities were tested. Results: In patients with PD, all ratios were significantly lower (P < 0.001) than those in patients with other movement disorders. No significant differences were found between the other groups tested. The manual method resulted in significantly lower values than did the standardized method (P < 0.001) and, for the putamen, showed significant differences between technologists. The standardized method showed no significant differences between technologists. The intra- and intertechnologist variabilities for this method were 0.14 ± 0.13 (confidence value, 2.4%) and 0.19 ± 0.18 (confidence value, 3.1%), respectively, whereas the intraclass correlation coefficients were 0.99 for 1 technologist and 0.98 for the 2 independent technologists. Conclusion: Our data confirm that 123I-FP-CIT SPECT has value in the differentiation of PD from other movement disorders. Acquisition using a triple-head {gamma}-camera and subsequent standardized analysis using fixed ROIs result in good intra- and intertechnologist agreement and can easily be applied in clinical practice.

Key Words: 123I-FP-CIT; movement disorders; triple-head {gamma}-camera; semiautomatic analysis







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE JOURNAL OF NUCLEAR MEDICINE JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
Copyright © 2007 by the Society of Nuclear Medicine Technologist Section.